F&V Capital Management, LLC Trevena Inc Transaction History

F&V Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 25, 2022	SELL	$0.2 - $0.5 $4,400 - $11,000	-22,000 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$0.39 - $3.47 $8,580 - $76,340	22,000 New	22,000 $9,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $717M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of F&V Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on F&V Capital Management, LLC with notifications on news.